SPOT Vision Screening

Status Recruiting

Clinical Trial Summary

The purpose of this protocol is to determine if the Welch-Allyn Spot Vision Screener (SPOT) is effective at detecting various risk factors for poor vision in developmentally delayed children. These children have a higher percentage of vision disorders than the average population. The SPOT screen itself takes about six seconds to complete. It produces a photograph of the eye and a print out with amount of hyperopia, myopia, astigmatism and pupil size. The subject will have three SPOT screens around the time of their standard of care eye exam. The data obtained from the three SPOT screens will be compared among themselves for accuracy and to the findings of the clinical eye exam.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Vision Disorders

Clinical Trial Details

NCT number	NCT03479021
Study type	Observational
Source	Children's Hospital Colorado
Contact	Kyle Phillips
Phone	720-777-0524
Email	kyle.phillips@childrenscolorado.org
Status	Recruiting
Phase
Start date	May 11, 2017
Completion date	May 31, 2019

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03872479` - Single Ascending Dose Study in Participants With LCA10	Phase 1/Phase 2
Active, not recruiting	`NCT02595502` - Clinical Evaluation of Two Silicone Hydrogel Daily Disposable Contact Lenses	N/A
Completed	`NCT02485054` - A Predictive Score for the Ischemic Etiology of a Transient Visual Disturbances (VASCO)
Completed	`NCT00985231` - Performance Evaluation of Contact Lenses Among a Population of Adapted Contact Lens Wearers	N/A
Recruiting	`NCT05208658` - Characteristics of the Vergence Responses of Binocularly Normal Subjects After a Vision Therapy Protocol	N/A
Recruiting	`NCT06077682` - Cycloplegic Refraction in Pediatric Patients With Esotropia	Phase 4
Active, not recruiting	`NCT04123626` - A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene	Phase 1/Phase 2
Recruiting	`NCT04693247` - Handheld Device Compared With a Standard Eye Care Diagnostic Device in Measuring Ophthalmic Refraction	N/A
Completed	`NCT01318577` - Study of A New Contact Lens Cleaning and Disinfecting Solution	N/A
Completed	`NCT03763721` - The ADVISE Study: Advanced Visualization In Corneal Surgery Evaluation	N/A
Completed	`NCT05602402` - To Evaluate the Efficacy and Safety of CAEP-01 on Eye Strain in Children With Heavy Screen Use	N/A
Not yet recruiting	`NCT06085430` - Kubota Glass Parameter Refinement Study	N/A
Completed	`NCT04347564` - Usability of the Software MacuFix for the Categorization of Metamorphopsia
Completed	`NCT01546402` - Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema	Phase 4
Completed	`NCT01698788` - Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular Edema	N/A
Completed	`NCT03169855` - Validation of Mesopic and Photopic Contrast Vision Tests With Respect to Nighttime Driving Ability
Terminated	`NCT03913130` - Extension Study to Study PQ-110-001 (NCT03140969)	Phase 1/Phase 2
Recruiting	`NCT05600140` - Viewing Strategy Training in Children With (Cerebral) Visual Impairment	N/A
Completed	`NCT03780257` - Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene	Phase 1/Phase 2
Recruiting	`NCT04855045` - An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene.	Phase 2/Phase 3